HomeOpen Access NewsDrug Development

Drug Development

Understanding the true impact of chronic pain

Chronic pain can affect a person’s life in a myriad of ways. Asal Shirazi BEM, Founder of the Autoimmune Support & Awareness Foundation (ASA Foundation), talks us through some of the conditions associated with chronic pain and the advancements in pain management.

Independent FDA Committee says Pfizer vaccine is ready for the US

The independent experts of the FDA say the Pfizer vaccine is good to go, which means that the COVID vaccine should be formally approved in a matter of days.

The advent of biomimetic apatites in today’s and tomorrow’s medicine

In this interview, Prof Christophe Drouet (CNRS Senior Scientist) – an international specialist in bio-inspired apatites – relates the multifunctional potential of these intrinsically biocompatible compounds for a wealth of uses from bone tissue repair, to cell-scale medicine.

The Moderna vaccine has a final efficiency of 94.1%

The clinical trials are over for the Moderna vaccine - the company announced their drug was 94.1% effective and then filed for Emergency Use.

Commission fines €60.5 million to pharma companies stopping cheaper medicine

Teva and Cephalon faced the €60.5 million antitrust fine, after both companies were found to be actively suppressing the existence of cheaper medicine.

AstraZeneca vaccine makes mistake in dose calculation

The Oxford and AstraZeneca vaccine trial gave an accidental half-dose to 3,000 people - but this mistake is the reason the vaccine acted as 90% efficient.

TRIPS agreement: A waiver makes the COVID-19 vaccine more accessible

Rachel Thrasher, Research Fellow at the Global Development Policy Center in Boston, says this time is different and the TRIPS Council knows it - the COVID-19 vaccine needs to be freely accessible to all countries.

US healthcare workers could get Pfizer vaccine in December

Today (20 November) Pfizer and BioNTech are sending their drug for approval to the FDA, meaning that the most vulnerable Americans could get the vaccine in December.

New kisspeptin drug could treat polycystic ovary syndrome

Imperial College London are working on clinical trials of a kisspeptin drug that could treat PCOS, HA and other reproductive health problems.

Moderna vaccine: New frontrunner is 95% effective against COVID-19

Eight days after the Pfizer vaccine results (90% effective) brought collective hope to the world, the Moderna vaccine has proven to be 95% effective at fighting COVID-19.

European Commission buys 300 million doses of Pfizer vaccine

While the US and UK sealed their BioNTech and Pfizer vaccine deals within 24 hours of the new results, the European Commission took 3 days longer to secure their larger order of 300 million doses.

Pfizer vaccine is more than 90% successful in preventing COVID-19

Created without US Government funding, the BioNTech and Pfizer vaccine is revealed to be over 90% effective against COVID-19.

New research suggests antidepressants could treat childhood cancer

Researchers found that a commonly used antidepressant could treat childhood cancer - successfully stopping growth in lab experiments so far.

EU Pharma Strategy: COVID-19 shows the need for diverse supply chains 

Rex Clements, CEO at Centrient Pharmaceuticals, discusses how the upcoming EU Pharma Strategy can prevent shortages and strengthen Europe’s manufacturing base, especially for antibiotics.

NHS saves millions on highly effective stroke drugs

Researchers from the Health Economics Unit and University of Leeds looked at the cost of treating strokes and found that the drugs prescribed are so effective they save the NHS money.

US healthcare: 34% of older people could be prescribed the wrong drugs

A new study found that it costs patients over $450 a year when they are prescribed the wrong drugs, making them twice as likely to go to hospital.

Research finds cannabis could reduce OCD symptoms by 50%

OCD symptoms could be eased by atleast half in the short-term, according to a new study published in the Journal of Affective Disorders.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders